Robert Eugene Kristal - 04 Nov 2021 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Chief Financial Officer
Signature
/s/ Robert Kristal
Issuer symbol
BRTX
Transactions as of
04 Nov 2021
Net transactions value
$0
Form type
4
Filing time
16 Nov 2021, 15:24:38 UTC
Next filing
11 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +10,490 $0.000000 10,490 04 Nov 2021 Common Stock 10,490 $13.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.